UNH
UnitedHealth Group Incorporated
NYSE: UNH · HEALTHCARE · HEALTHCARE PLANS
$413.00
+1.58% today
Updated 2026-06-09
Market cap
$343.21B
P/E ratio
28.50
P/S ratio
0.76x
EPS (TTM)
$13.26
Dividend yield
2.33%
52W range
$230 – $404
Volume
8.0M
WallStSmart proprietary scores
54
out of 100
Grade: C
Hold
Investment rating
5.3
Growth
C+5.5
Quality
C+5.5
Profitability
C+4.7
Valuation
C4/9
Piotroski F-Score
Moderate
2.3
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →209 stocks currently score above 75
Price targets
Analyst target
$407.38
-1.36%
12-Month target
$216.44
-47.59%
Intrinsic (DCF)
$321.13
Margin of safety
-26.61%
6 Strong Buy16 Buy5 Hold1 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $8.15B — positive
Risks
- Thin margins at 2.68%
- 26.61% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $324.16B | $371.62B | $400.28B | $447.57B | $449.71B | $444.4B |
| Net income | $20.12B | $22.38B | $14.40B | $12.06B | $6.28B | — |
| EPS | — | — | — | — | $13.26 | $18.39 |
| Free cash flow | $23.40B | $25.68B | $20.70B | $16.07B | $8.15B | — |
| Profit margin | 6.21% | 6.02% | 3.60% | 2.69% | 2.68% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-03 | ZAETTA, CHRISTOPHER R | Sale | 134 | $377.00 |
| 2026-06-02 | CONWAY, PATRICK HUGH | Sale | 204 | $377.92 |
| 2026-04-23 | CONWAY, PATRICK HUGH | Sale | 800 | $355.00 |
Peer comparison
Smart narrative
UnitedHealth Group Incorporated trades at $413.00. representing a P/E of 28.50x trailing earnings. Our Smart Value Score of 54/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 2.28, it sits in the grey zone. TTM revenue stands at $449.71B. with profit margins at 2.68%. Our DCF model estimates intrinsic value at $321.13.
Frequently asked questions
What is UnitedHealth Group Incorporated's stock price?
UnitedHealth Group Incorporated (UNH) trades at $413.00, on a P/E of 28.5x and a P/S of 0.8x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is UnitedHealth Group Incorporated overvalued?
UnitedHealth Group Incorporated carries a Smart Value Score of 54/100 (Grade C), which we rate Hold. That score blends growth, quality, and valuation into one read. On valuation specifically, our conservative DCF puts intrinsic value at $321.13 against the $413.00 price, so on cash flow terms the market is paying a premium for UnitedHealth Group Incorporated's growth. The Hold rating reflects that growth and quality, while the DCF flags that the price already assumes a lot.
What is the price target of UnitedHealth Group Incorporated (UNH)?
The 12-month analyst consensus target is $407.38, about 1.4% below the current $413.00. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of UNH by 2030?
Our research-backed model puts the 2030 base case at $626.50, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is the intrinsic value of UnitedHealth Group Incorporated (UNH)?
Our DCF model estimates intrinsic value at $321.13, a -26.6% margin of safety versus today's $413.00. Intrinsic value is what the projected cash flows are worth today. A negative reading means the price is running ahead of that conservative estimate, leaving little downside cushion if growth slows.
What is UnitedHealth Group Incorporated's revenue?
UnitedHealth Group Incorporated's trailing twelve-month revenue is $449.71B, and our model projects it reaching about $579.10B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
UnitedHealth Group Incorporated's Altman Z-Score is 2.28, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryHEALTHCARE PLANS
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.76x
ROE11.59%
Beta0.65
50D MA$342.37
200D MA$327.68
Shares out0.91B
Float0.91B
Short ratio—
Avg volume8.0M
Performance
1 week+5.96%
1 month+3.91%
3 months+40.04%
YTD+21.95%
1 year+35.23%
3 years-14.13%
5 years—